Citigroup’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.17M | Buy |
76,177
+47,986
| +170% | +$1.04M | ﹤0.01% | 2869 |
|
|
2026
Q1 | $489K | Buy |
28,191
+796
| +3% | +$15.1K | ﹤0.01% | 3559 |
|
|
2025
Q4 | $516K | Buy |
27,395
+6,866
| +33% | +$115K | ﹤0.01% | 3558 |
|
|
2025
Q3 | $298K | Sell |
20,529
-15,062
| -42% | -$215K | ﹤0.01% | 3816 |
|
|
2025
Q2 | $695K | Sell |
35,591
-78,671
| -69% | -$1.4M | ﹤0.01% | 3413 |
|
|
2025
Q1 | $2.03M | Buy |
114,262
+22,199
| +24% | +$478K | ﹤0.01% | 2700 |
|
|
2024
Q4 | $1.97M | Buy |
92,063
+50,893
| +124% | +$1.24M | ﹤0.01% | 2836 |
|
|
2024
Q3 | $1.29M | Buy |
41,170
+8,795
| +27% | +$219K | ﹤0.01% | 3053 |
|
|
2024
Q2 | $503K | Sell |
32,375
-359,446
| -92% | -$4.34M | ﹤0.01% | 3392 |
|
|
2024
Q1 | $4.15M | Buy |
391,821
+309,084
| +374% | +$3.09M | ﹤0.01% | 1847 |
|
|
2023
Q4 | $993K | Sell |
82,737
-49,823
| -38% | -$408K | ﹤0.01% | 2831 |
|
|
2023
Q3 | $928K | Buy |
132,560
+8,768
| +7% | +$81K | ﹤0.01% | 2585 |
|
|
2023
Q2 | $1.05M | Sell |
123,792
-204,771
| -62% | -$1.71M | ﹤0.01% | 2811 |
|
|
2023
Q1 | $3M | Buy |
328,563
+108,809
| +50% | +$1.39M | ﹤0.01% | 1760 |
|
|
2022
Q4 | $2.51M | Sell |
219,754
-50,815
| -19% | -$753K | ﹤0.01% | 1870 |
|
|
2022
Q3 | $4.61M | Buy |
270,569
+90,455
| +50% | +$1.94M | ﹤0.01% | 1600 |
|
|
2022
Q2 | $3.87M | Buy |
180,114
+137,558
| +323% | +$3.81M | ﹤0.01% | 1680 |
|
|
2022
Q1 | $1.57M | Sell |
42,556
-73,740
| -63% | -$2.87M | ﹤0.01% | 2550 |
|
|
2021
Q4 | $5.29M | Buy |
116,296
+67,057
| +136% | +$3.5M | ﹤0.01% | 1786 |
|
|
2021
Q3 | $3.12M | Sell |
49,239
-17,902
| -27% | -$1.36M | ﹤0.01% | 2157 |
|
|
2021
Q2 | $6.14M | Sell |
67,141
-4,298
| -6% | -$342K | ﹤0.01% | 1746 |
|
|
2021
Q1 | $4.86M | Buy |
71,439
+44,840
| +169% | +$3.48M | ﹤0.01% | 1806 |
|
|
2020
Q4 | $1.93M | Buy |
26,599
+17,508
| +193% | +$1.01M | ﹤0.01% | 2893 |
|
|
2020
Q3 | $345K | Sell |
9,091
-32,497
| -78% | -$1.1M | ﹤0.01% | 4173 |
|
|
2020
Q2 | $1.47M | Sell |
41,588
-8,650
| -17% | -$246K | ﹤0.01% | 3144 |
|
|
2020
Q1 | $1.1M | Buy |
50,238
+41,867
| +500% | +$938K | ﹤0.01% | 3073 |
|
|
2019
Q4 | $181K | Sell |
8,371
-100,065
| -92% | -$2.3M | ﹤0.01% | 5262 |
|
|
2019
Q3 | $2.45M | Buy |
108,436
+49,724
| +85% | +$1.38M | ﹤0.01% | 2642 |
|
|
2019
Q2 | $2.11M | Buy |
58,712
+52,160
| +796% | +$1.67M | ﹤0.01% | 2788 |
|
|
2019
Q1 | $206K | Sell |
6,552
-87,272
| -93% | -$2.54M | ﹤0.01% | 5072 |
|
|
2018
Q4 | $2.36M | Buy |
93,824
+82,073
| +698% | +$2.11M | ﹤0.01% | 2519 |
|
|
2018
Q3 | $339K | Buy |
11,751
+7,022
| +148% | +$131K | ﹤0.01% | 4704 |
|
|
2018
Q2 | $58K | Buy |
+4,729
| New | +$54.2K | ﹤0.01% | 6163 |
|
Other funds holding CDNA
DM
AIM
GS
Citigroup's CDNA Position: Q2 2026 in Review
Citigroup increased its CareDx (CDNA) stake by 170% in Q2 2026, buying an estimated $1.04M and bringing the position to 76,177 shares worth $2.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2869.
Citigroup first reported a position in CDNA in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.14M in Q2 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Citigroup held 76,177 shares of CareDx worth $2.17M as of Q2 2026.
- Citigroup bought 47,986 CareDx shares in Q2 2026, an estimated $1.04M.
- CareDx made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #2869 holding.
- Citigroup first reported a position in CareDx in Q2 2018 and has held it in 33 quarters since.
- Citigroup's CareDx position peaked at $6.14M in Q2 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.